Larimar Therapeutics, Inc.
Status: Publicly traded
Direct answer
Larimar Therapeutics, Inc. is publicly traded on NASDAQ under the ticker LRMR.
Headquartered in Bala Cynwyd, Pennsylvania, Larimar Therapeutics, Inc. operates as a clinical-stage biotechnology firm. Its core mission involves crafting therapies for rare diseases, leveraging a distinctive cell-penetrating peptide technology platform. The company's foremost experimental therapy, CTI-1601, is presently undergoing Phase 1 clinical trials. This drug candidate is being developed to combat...
Can you invest in Larimar Therapeutics, Inc.?
Yes. Larimar Therapeutics, Inc. is publicly traded on NASDAQ under the ticker LRMR.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Larimar Therapeutics, Inc.
Detailed equity research is provided by MarketSnap.